Elite Labs Inc Company Profile

What is the competitive landscape for ELITE LABS INC, and what generic and branded alternatives to ELITE LABS INC drugs are available?

ELITE LABS INC has seventeen approved drugs.

Summary for Elite Labs Inc

US Patents:	0
Tradenames:	12
Ingredients:	12
NDAs:	17

Drugs and US Patents for Elite Labs Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Elite Labs Inc	ISRADIPINE	isradipine	CAPSULE;ORAL	077169-001	Apr 24, 2006	AB	RX	No	No
Elite Labs Inc	PHENDIMETRAZINE TARTRATE	phendimetrazine tartrate	TABLET;ORAL	040762-001	Jan 28, 2008	AA	RX	No	No
Elite Labs Inc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	209385-003	Jul 2, 2018	AA	RX	No	No
Elite Labs Inc	DANTROLENE SODIUM	dantrolene sodium	CAPSULE;ORAL	076686-003	Oct 24, 2005	AB	RX	No	No
Elite Labs Inc	PHENTERMINE HYDROCHLORIDE	phentermine hydrochloride	TABLET;ORAL	040190-001	May 30, 1997	AA	RX	No	No
Elite Labs Inc	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	212037-006	Dec 11, 2019	AB1	RX	No	No
Elite Labs Inc	DANTROLENE SODIUM	dantrolene sodium	CAPSULE;ORAL	076686-002	Oct 24, 2005	AB	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Elite Labs
• Elite Labs Inc
• Elite Pharm Solution